During the past decade, The Medical Group of Texas conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 17 clinical trials were completed, i.e. on average, 113.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 13 clinical trials were completed. i.e. 260% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Medical Group of Texas" #1 sponsor was "Pfizer" with 8 trials, followed by "AstraZeneca" with 2 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored, "Acclarent" with 1 trials sponsored and "Aerin Medical" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Medical Group of Texas" #1 collaborator was "Cyclerion Therapeutics" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "The Medical Group of Texas" are "Cardiovascular Disease" (3 trials), "Chronic Rhinitis" (2 trials), "Diabetic Kidney Disease" (2 trials), "Alzheimer´s Disease" (1 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "The Medical Group of Texas" in a lesser frequency.

Most popular intervention types in "The Medical Group of Texas" are "Drug" (15 trials), "Biological" (5 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "bococizumab (PF-04950615)" (2 trials), "ASP3772" (1 trials), "Acclarent Eustachian Tube Balloon Catheter (ETBC)" (1 trials) and "CR845" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Medical Group of Texas" are 21 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "The Medical Group of Texas". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in The Medical Group of Texas, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in The Medical Group of Texas, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".